Older people admitted to hospital Other
Conditions
Interventions
The trialists will recruit approximately 3,588 patients aged 65 and older, who have been admitted to acute wards in hospitals in Oxfordshire, Cambridgeshire and Devon. Half of the study participants w
Sponsors
University of Oxford
Eligibility
Sex/Gender
All
Age
65 Years to 100 Years
Inclusion criteria
Inclusion criteria: To be included in the study patients must: 1. Be an inpatient in an acute ward 2. Have been admitted non-electively 3. Be aged 65 years or older 4. Be expected (by their clinical team) to remain an inpatient for at least 2 days from the time of baseline assessment 5. Be able to give informed consent or if unable to give consent, a consultee advises that study participation is appropriate
Exclusion criteria
Exclusion criteria: Patients will be excluded if: 1. They are moribund (defined as when the clinicians caring for a patient estimate that they are likely to die before discharge from hospital) 2. Their participation in the study is judged to be clinically or practically inappropriate (e.g. patient visiting from overseas) 3. They have already been enrolled in the study 4. They have already been referred to the usual liaison psychiatry team. 5. They have been a general hospital inpatient continuously for 1 week at the time of the baseline assessment 6. They do not read or speak English
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of days spent as an inpatient in a general hospital in the month (30 days) post-randomisation; Timepoint(s): 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 17/10/2022: 1. Cognitive function, measured using MOCA-T at 1 and 3 months 2. Independent functioning, measured using Barthel Index of Activities of Daily Living at 1 and 3 months 3. Health-related quality of life, measured using EQ-5D-5L at 1 and 3 months 4. Symptoms of anxiety and depression, measured using PHQ-4 at 1 and 3 months 5. Overall quality of life, measured using study-specific item at 1 and 3 months 6. Patient’s experience of hospital stay, measured using study-specific item at 1 month 7. Patient’s view on the length of their hospital stay, measured using study-specific item at 1 month 8. Discharge destination 9. Secondary healthcare use (including total length of index admission, length of index admission truncated at 30 days, number of readmissions, number of days in hospital) in the year post-randomisation 10. Death in the year post-randomisation Previous secondary outcome measures as of 15/02/2018: 1. Cognitive function, measured using MOCA-T at 1 and 3 months 2. Independent functioning, measured using Barthel Index of Activities of Daily Living at 1 and 3 months 3. Health-related quality of life, measured using EQ-5D-5L at 1 and 3 months 4. Symptoms of anxiety and depression, measured using PHQ-4 at 1 and 3 months 5. Overall quality of life, measured using study-specific item at 1 and 3 months 6. Patient’s experience of hospital stay, measured using study-specific item at 1 month 7. Patient’s view on the length of their hospital stay, measured using study-specific item at 1 month 8. Discharge destination 9. Secondary healthcare use (including total length of index admission, number of readmissions, number of days in hospital) in the year post-randomisation 10. Death in the year post-randomisation Previous secondary outcome measures: 1. Cognitive function, measured using MOCA-T at 1 and 3 months 2. Independent functioning, measured using Barthel Index of Activities of Daily Living at 1 and 3 months 3. Healt | — |
Countries
England, United Kingdom
Outcome results
None listed